FDA wins legal dispute with Vanda over partial clinical hold

The FDA has won a legal dispute with Vanda Pharmaceuticals over a partial clinical hold it imposed on tradipitant. Vanda took the FDA to court in the belief the agency's demand ran counter to scientific evidence but failed to convince the U.S. District Court for the District of Columbia.